Nestle Forms Botanical-Medicine Venture With Li’s Chi-Med

Nestle SA and Hutchison China Meditech Ltd., the drugmaker controlled by Hong Kong billionaire Li Ka-shing, agreed to form an alliance to develop gastro-intestinal treatments based on traditional Chinese medicines.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.